Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow

被引:3
|
作者
Patel, Shivani G. [1 ,2 ]
Husain, Nazia [1 ,2 ]
Rigsby, Cynthia K. [2 ,3 ,4 ]
Robinson, Joshua D. [1 ,2 ,4 ]
机构
[1] Ann & Robert H Lurie Childrens Hosp Chicago, Div Cardiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Med Imaging, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA
来源
CHILDREN-BASEL | 2022年 / 9卷 / 09期
关键词
pediatric; stress perfusion MRI; regadenoson; CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; RESERVE;
D O I
10.3390/children9091332
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Myocardial stress perfusion magnetic resonance imaging is a non-invasive tool to assess for myocardial ischemia and viability. Pediatric myocardial stress perfusion MRI can be challenging due to multiple intravenous lines, sedation, inadequate breath holding, fast heart rates, and complex anatomy. We performed a retrospective analysis in 39 children to evaluate safety and efficacy of regadenoson, a coronary vasodilator administered via a single intravenous line (6-10 mcg/kg), with respiratory motion correction (MOCO) and semi-quantitative blood flow analysis. Stress response data and adverse events were recorded, and image quality compared between native and MOCO reconstructions, assessing for perfusion deficits. Semi-quantitative analysis compared myocardial perfusion reserve index (MPRI) between patients who had a focal perfusion defect, patients who had undergone an orthotopic heart transplant, and non-transplant patients with no focal defects. Stress perfusion was completed in 38/39 patients (median age 15 years with a 41 +/- 27% rise in heart rate (p < 0.005). Fifteen out of thirty-eight had transient minor side effects with no major adverse events. MOCO image quality was better than non-MOCO (4.63 vs. 4.01 at rest, p < 0.005: 4.41 vs. 3.84 at stress, p < 0.005). Reversible perfusion defects were seen in 4/38 patients with lower segmental mean MPRI in the area of the perfusion defect, nearing statistical significance when compared to non-transplant patients with no defects (0.78 +/- 0.22 vs. 0.99 +/- 0.36, p = 0.07). The global MPRI of the 16 patients who had undergone orthotopic heart transplant was significantly lower than the non-transplant patients (0.75 +/- 0.22 vs. 0.92 +/- 0.23, p = 0.03). Regadenoson is a safe and effective coronary vasodilator for pediatric stress perfusion MRI with MOCO producing better image quality and allowing for semi-quantitative assessment of perfusion deficits that correlate with qualitative assessment.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Safety and efficacy of Regadenoson in myocardial perfusion imaging (MPI) stress tests: A review
    Ahmed, Ambereen
    QUANTITATIVE PHASE IMAGING IV, 2018, 10503
  • [2] Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
    Bradley D Allen
    Neil Chatterjee
    Jad Bou Ayache
    Benjamin H Freed
    Daniel C Lee
    Timothy Carroll
    Michael Markl
    Jeremy D Collins
    James C Carr
    Journal of Cardiovascular Magnetic Resonance, 17 (Suppl 1)
  • [3] Safety of regadenoson for vasodilation in cardiac MRI stress tests
    Bastarrika, G.
    Ezponda, A.
    Garcia Baizan, A.
    Calvo, M.
    Pueyo, J. C.
    Gavira, J. J.
    Caballeros, M.
    RADIOLOGIA, 2020, 62 (03): : 213 - 221
  • [4] Regadenoson stress for myocardial perfusion imaging
    Reyes, Eliana
    FUTURE CARDIOLOGY, 2016, 12 (01) : 59 - 67
  • [5] Regadenoson safety and tolerability in myocardial perfusion imaging
    Catalano, M.
    Annunziata, G.
    Sasso, A.
    Gottilla, R.
    Scala, D.
    Ippolito, V.
    Valenti, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S516 - S516
  • [6] Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
    Roczniak, Jan
    Baczalska, Justyna
    Kanclerz, Gabriela
    Zielinska, Weronika
    Ozga, Joanna
    Cymerman, Blazej
    Stepien, Agnieszka
    Kostkiewicz, Magdalena
    Holcman, Katarzyna
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 131 - 137
  • [7] Three-dimensional quantification of myocardial perfusion during regadenoson stress computed tomography
    Mor-Avi, Victor
    Kachenoura, Nadjia
    Maffessanti, Francesco
    Bhave, Nicole M.
    Port, Steven
    Lodato, Joseph A.
    Chandra, Sonal
    Freed, Benjamin H.
    Lang, Roberto M.
    Patel, Amit R.
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (05) : 885 - 892
  • [8] GENDER DIFFERENCES IN MYOCARDIAL BLOOD FLOW IN CARDIAC PET/CT WITH REGADENOSON
    Allen, Jason
    Mason, Steve
    Ethington, Jon-David
    Anderson, Jeffrey
    McCubrey, Raymond
    Le, Viet
    Dhar, Ritesh
    Meredith, Kent G.
    Raasch, Hannah
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1270 - A1270
  • [9] Quantification of Myocardial Perfusion: MRI
    Jerosch-Herold M.
    Shah R.V.
    Current Cardiovascular Imaging Reports, 2012, 5 (3) : 158 - 166
  • [10] Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson
    Cory V. Noel
    Ramkumar Krishnamurthy
    Prakash Masand
    Brady Moffett
    Tobiash Schlingmann
    Benjamin Y. Cheong
    Rajesh Krishnamurthy
    Pediatric Cardiology, 2018, 39 : 1249 - 1257